(Recasts; adds details, context throughout) SHANGHAI/BEIJING, Nov 14 (Reuters) – GLP-1 drugs from Pfizer and Innovent Biologics will be added to China's state-run health insurance scheme from January
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Milana Vinn, Echo Wang and Krystal Hu Nov 13 (Reuters) - Institutional-investor interest in Anthropic’s…
Nov 14 (Stats Perform) - Results from the NCAAB games on Friday (home team in…
EVERETT, WASHINGTON, Nov 14 (Reuters) - American Ilia Malinin shrugged off a minor error to…
By David Shepardson, Doyinsola Oladipo and Rajesh Kumar Singh WASHINGTON, Nov 13 (Reuters) - The…
Nov 13 (Reuters) - Nvidia's board has approached British chipmaker Arm Holdings CEO Rene Haas…
Nov 14 (Stats Perform) - Standings from the NBA games on Saturday Eastern Conference Atlantic…